MS drug Tysabri shows promise in efforts to combat HIV’s ‘viral reservoirs’

A drug now used to treat Crohn’s disease and multiple sclerosis has shown effectiveness in lab experiments in blocking viral reservoirs, which have been tied to illnesses that afflict people living with HIV, Boston College biologists and colleagues reported in the journal PLOS Pathogens. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *